ES2052802T3 - Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina. - Google Patents

Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina.

Info

Publication number
ES2052802T3
ES2052802T3 ES89107231T ES89107231T ES2052802T3 ES 2052802 T3 ES2052802 T3 ES 2052802T3 ES 89107231 T ES89107231 T ES 89107231T ES 89107231 T ES89107231 T ES 89107231T ES 2052802 T3 ES2052802 T3 ES 2052802T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
acethylcisteine
mouth containing
compositions soluble
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89107231T
Other languages
English (en)
Inventor
Antonio Ziggiotti
Paolo Lualdi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altergon SA
Original Assignee
Altergon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon SA filed Critical Altergon SA
Application granted granted Critical
Publication of ES2052802T3 publication Critical patent/ES2052802T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS MASTICABLEMENTE SOLUBLES COMPRENDIENDO ACETILQUISTEINA, BICARBONATOS ALCALINOS, CARBOHIDRATOS Y AROMAS DE FRUTAS, PRODUCIDAS EN FORMA DE TABLETAS PARA TRATAMIENTO DE AFECCIONES DE LA CAVIDAD ORAL.
ES89107231T 1988-04-29 1989-04-21 Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina. Expired - Lifetime ES2052802T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20386/88A IT1217445B (it) 1988-04-29 1988-04-29 Composizione farmaceutiche orosolubili contenti acetilcisteina

Publications (1)

Publication Number Publication Date
ES2052802T3 true ES2052802T3 (es) 1994-07-16

Family

ID=11166252

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89107231T Expired - Lifetime ES2052802T3 (es) 1988-04-29 1989-04-21 Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina.

Country Status (6)

Country Link
US (1) US4970236A (es)
EP (1) EP0339508B1 (es)
AT (1) ATE83651T1 (es)
DE (1) DE68903988T2 (es)
ES (1) ES2052802T3 (es)
IT (1) IT1217445B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
DE59106133D1 (de) * 1990-10-19 1995-09-07 Spirig Ag Feste, schnell-lösliche Arzneimittelzubereitung enthaltend S-(Carboxymethyl)-L-Cystein und/oder N-Acetylcystein.
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
WO1995017900A1 (en) * 1993-12-30 1995-07-06 Arcturus Pharmaceutical Corporation Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
ES2114817B1 (es) * 1996-05-16 1999-02-16 Zambon S A Asociacion farmacologica entre n-acetilcisteina y levulosa para la prevencion de la muerte celular y enfermedades asociadas.
US5962421A (en) * 1996-05-16 1999-10-05 Zambon, S.A. Pharmacological association between N-acetylcysteine and levulose for preventing cellular death and related diseases
US5719196A (en) * 1996-07-24 1998-02-17 Leiras Oy Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
DE839528T1 (de) * 1996-10-29 1998-10-22 Staroil Ltd Mundlösliche Zusammensetzungen die N-Acetylcystein und Cyclodextrin enthalten
AU3072397A (en) * 1996-11-20 1998-06-10 Sang Whang Enterprises, Inc. Potassium and sodium bicarbonate for increased blood buffers
US6258848B1 (en) 1998-07-31 2001-07-10 Mount Sinai Hospital Methods and compositions for increasing insulin sensitivity
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
IT1399492B1 (it) 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
US10139321B2 (en) * 2016-07-29 2018-11-27 Alpha-Tec Systems, Inc. Mucolytic tablet for a sample collection device
WO2019051182A1 (en) 2017-09-07 2019-03-14 The Children's Hospital Of Philadelphia COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTATIN C-HISTORY AMYLOID ANGIOPATHY (HCCAA) AND OTHER NEURODEGENERATIVE DISORDERS ASSOCIATED WITH ABERRANT AMYLOID DEPOTS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE304574C (es) *
US2888380A (en) * 1954-11-05 1959-05-26 Merck & Co Inc S-ethyl cysteine compositions for combatting tubercle bacilli
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
FR1451177A (fr) * 1962-03-06 1966-01-07 Degussa Procédé de préparation d'une n-acylhomocystéine thiolactone
US3591686A (en) * 1967-08-01 1971-07-06 Mead Johnson & Co Anti-inflammatory compositions and methods utilizing n-acylcysteines and the beta-alkyl and carboxyl derivatives thereof
US3629452A (en) * 1968-02-19 1971-12-21 Oreal Method of reducing excessive secretions of sebum by oral administration of amino acid derivatives
USRE29256E (en) * 1969-10-07 1977-06-07 Recherche Pharmaceutiques Et Scientifiques Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
CA1080024A (en) * 1975-12-24 1980-06-24 Leonard Spooner Confection containing xylitol
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives
IT1194474B (it) * 1983-11-23 1988-09-22 Magis Farmaceutici Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
JPH0610132B2 (ja) * 1985-11-27 1994-02-09 千寿製薬株式会社 糖尿病性白内障治療薬
CH666814A5 (it) * 1986-07-24 1988-08-31 Inpharzam Int Sa Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .

Also Published As

Publication number Publication date
US4970236A (en) 1990-11-13
ATE83651T1 (de) 1993-01-15
IT8820386A0 (it) 1988-04-29
DE68903988D1 (de) 1993-02-04
DE68903988T2 (de) 1993-06-17
EP0339508A1 (en) 1989-11-02
EP0339508B1 (en) 1992-12-23
IT1217445B (it) 1990-03-22

Similar Documents

Publication Publication Date Title
ES2052802T3 (es) Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina.
BR1100776A (pt) Forma de dosagem farmacêutica comprimida e obréia farmacêutica comprimida.
NO175564C (no) Fremgangsmåte for fremstilling av et peroralt, osmotisk virkende system for tungtopplöselige terapeutiske stoffer
DE59004042D1 (de) Mund- und zahnpflegemittel.
CA2029046A1 (en) Sustained release compositions for treating periodontal disease
PT1213015E (pt) Composicao farmaceutica oral com libertacao retardada de inibidores da bomba de protoes
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
AU3805795A (en) Polyol composition obtainable by co-spray-drying
DE68903732D1 (de) Synergistische suessungsmittel-zusammensetzungen, die chlorodeoxy-zucker und maltitol enthalten, und verfahren zur herstellung derselben.
EA199900028A1 (ru) Быстроразлагаемая внутрибуккально таблетка
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
DE69936430D1 (de) Verfahren zur Herstellung von in der Mundhöhle rasch zerfallenden Tabletten
MXPA01004547A (es) Administracion oral de analogos de adenosina.
NO874873L (no) Anordning for autoadministrering av fysiologisk aktive stoffer, med forhindring av overdosering.
SE8902288L (sv) Farmaceutisk komposition
GR3017161T3 (en) Multi-fractionable tablet structure.
EP1167354A3 (en) Racemic huperzine A
AU1244199A (en) Tablets to be crunched or sucked, comprising iron as active principle
DE69518229D1 (de) Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält
IT8722264A0 (it) Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute.
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
WO2002045618A3 (de) Schluck-kapsel zur tabletten-einnahme bei tieren
JPS5234942A (en) Tooth paste composition
ZA991068B (en) Novel disubstituted naphthyl derivatives, their preparation, pharmaceutical compositions which contain them and their use for the preparation of medicinal products.
EG18590A (en) New pharmaceutical compositions in the form of beadlets and method.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 339508

Country of ref document: ES